pharmaceutical investing Summit Awarded Additional $12 Million by BARDA for Phase 3 Development Programme of Ridinilazole for the Treatment of C. difficile Infection
Homerun Resources Inc. Announces Advancement of Road Improvements Servicing Santa Maria Eterna Silica and Solar Glass Hub
